Shares of Roche Holding AG (OTCMKTS:SNYNF) were up 0.8% during trading on Wednesday . The stock traded as high as $84.85 and last traded at $84.54, approximately 5,204 shares were traded during trading. A decline of 54% from the average daily volume of 11,216 shares. The stock had previously closed at $83.90.

Separately, Jefferies Financial Group reaffirmed a “buy” rating and set a $95.00 price target on shares of Roche in a research report on Wednesday, July 10th.

About Roche (OTCMKTS:SNYNF)

Sanofi provides therapeutic solutions worldwide. It offers Cerezyme and Cerdelga for Gaucher, Myozyme and Lumizyme for Pompe, Fabrazyme for Fabry, and Aldurazyme for mucopolysaccharidosis Type 1; and Aubagio, an immunomodulatory and Lemtrada, a monoclonal antibody for multiple sclerosis. It also provides Dupixent for atopic dermatitis; Kevzara for rheumatoid arthritis; Eloctate and Alprolix to treat hemophilia in adults and children; and Cablivi to treat acquired thrombotic thrombocytopenic purpura in adults.

Read More: What is a Buy-Side Analyst?

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.